Journal of Multiple Sclerosis and Neuroimmunology

The Importance of Cautious Interpretation and Differential Diagnosis in Low-Titer MOG Antibody Positivity: Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2025;16(1):33-34. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.33-34; Full text PubReader ePub PDF

Clinical Manifestation and Prognosis of Overlapping Acute Motor Axonal Neuropathy and Acute Transverse Myelitis with Anti-GM1 and Anti-GD1a Antibodies: A Case Study: A Young Kim, Hong Keun Yoo, Jong Hyun Jeon, Hyuk Sung Kwon; J Mult Scler Neuroimmunol. 2025;16(1):26-32. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.26-32; Full text PubReader ePub PDF

Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France: Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset; J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25; Full text PubReader ePub PDF Supplementary Material

Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders: Ki Hoon Kim, Young Nam Kwon, Jun-Soon Kim, Sooyoung Kim, Seung Woo Kim, Kee Hong Park, Jin-Sung Park, Jeong Bin Bong, Jin Myoung Seok, Hung Youl Seok, Hye Lim Lee, Eunbin Cho, Byeoung-Jun Jeon, Seong-il Oh, Public Relations Committee of Korean Society for Neuroimmunology; J Mult Scler Neuroimmunol. 2025;16(1):8-18. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.8-18; Full text PubReader ePub PDF

Diagnosis and Management of Neurological Immune Related Adverse Events: Jae-Won Hyun; J Mult Scler Neuroimmunol. 2025;16(1):1-7. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.1-7; Full text PubReader ePub PDF

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis: Jun-Soon Kim; J Mult Scler Neuroimmunol. 2024;15(2):85-86. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.85-86
Cited By 1; Full text PubReader ePub PDF

A Case Report of MOG Antibody-Associated Disease (MOGAD) with Isolated Brainstem and Spinal Cord Involvement: Ye Lin Kim, Juhee Chae, Sun-Young Oh; J Mult Scler Neuroimmunol. 2024;15(2):81-84. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.81-84; Full text PubReader ePub PDF

Temporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis: Byeong Cheol Oh, Ha Young Shin, Young Ho Yang, Seung Woo Kim; J Mult Scler Neuroimmunol. 2024;15(2):72-80. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.72-80; Full text PubReader ePub PDF Supplementary Material

National Consensus Guidance for Management of Refractory Myasthenia Gravis: Hyung-Soo Lee, Hye Yoon Chung, Seung Woo Kim, Eunhee Sohn, Tai-Seung Nam, Kyong Jin Shin, Sa-Yoon Kang, Hyunjin Kim, Jin-Sung Park, Byeol-A Yoon, Hung Youl Seok, Jeong Bin Bong, Yeon-Kyung Jung, Yoon-Ho Hong, Ha Young Shin; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71; Full text PubReader ePub PDF

Summary of Cladribine (from Development to Clinical and Practical Treatment): Kyong Jin Shin; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis: Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

Eculizumab Therapy in Neuromyelitis Optica Spectrum Disorder: Jee Eun Kim, Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

An Immunoglobulin G4-Related Hypertrophic Pachymeningitis Involving Cerebral Parenchyma: Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):40-41. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.40; Full text PubReader ePub PDF

Emotional Incontinence in a Patient with Neuromyelitis Optica Spectrum Disorder: Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(1):35-39. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.35; Full text PubReader ePub PDF

Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis: Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

7,625	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,170	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
3,748	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,618	Rituximab Treatment for Neuroimmunologic Disorders
2,965	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By 4	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By 1	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Search